Community-acquired pneumonia in southeast Asia: the microbial differences between ambulatory and hospitalized patients.

STUDY OBJECTIVES To determine microbial agents causing community-acquired pneumonia (CAP) in Southeast Asia. DESIGN A prospective study. SETTING Three general hospitals in Thailand. PATIENTS Two hundred forty-five adult patients fulfilling the clinical criteria of CAP from September 1998 to April 2001. INTERVENTIONS Investigations included sputum Gram stain and culture, blood culture, pleural fluid culture (if presented), urine antigen for Legionella pneumophila and Streptococcus pneumoniae, and serology for Mycoplasma pneumoniae, Chlamydia pneumoniae, and L pneumophila. RESULTS There were 98 outpatients and 147 hospitalized patients included in the study, and an organism was identified in 74 of 98 outpatients (75.5%) and 105 of 147 of the hospitalized patients (71.4%). C pneumoniae (36.7%), M pneumoniae (29.6%), and S pneumoniae (13.3%) were the most frequent causative pathogens found in outpatients, while S pneumoniae (22.4%) and C pneumoniae (16.3%) were the most common in hospitalized patients. There was a significantly higher incidence of C pneumoniae (36.7% vs 16.3%, respectively; p < 0.001) and M pneumoniae (29.6% vs 6.8%; p < 0.001, respectively) in the outpatients than in the hospitalized patients. The incidence of S pneumoniae, L pneumophila, and mixed infections was not different between the groups. Mixed infections were presented in 13 of 98 outpatients (13.3%) and 9 of 147 hospitalized patients (6.1%), with C pneumoniae being the most frequent coinfecting pathogen. CONCLUSIONS The data indicate that the core organisms causing CAP in Southeast Asia are not different from those in the Western countries. The guidelines for the treatment of patients with CAP, therefore, should be the same.

[1]  P. León,et al.  Diagnosis ofMycoplasma pneumoniae infection by microparticle aggluination and antibody-capture enzyme-immunoassay , 1990, European Journal of Clinical Microbiology and Infectious Diseases.

[2]  N. Miyashita,et al.  Etiology of community-acquired pneumonia requiring hospitalization in Japan. , 2001, Chest.

[3]  M. Leinonen,et al.  role of serum troponin levels combined with electrocardiographic findings Study of community acquired pneumonia aetiology (SCAPA) in adults admitted to hospital: implications for management guidelines , 2001 .

[4]  P. Francioli,et al.  Community-Acquired Pneumonia: A Prospective Outpatient Study , 2001, Medicine.

[5]  C. Prat,et al.  Detection of Streptococcus pneumoniae antigen by a rapid immunochromatographic assay in urine samples. , 2001, Chest.

[6]  M. Fine,et al.  Guidelines for the management of adults with community-acquired pneumonia. Diagnosis, assessment of severity, antimicrobial therapy, and prevention. , 2001, American journal of respiratory and critical care medicine.

[7]  B. Fields,et al.  Evaluation of the Binax and Biotest Urinary Antigen Kits for Detection of Legionnaires' Disease Due to Multiple Serogroups and Species of Legionella , 2000, Journal of Clinical Microbiology.

[8]  A. Torres,et al.  Etiology of community-acquired pneumonia: impact of age, comorbidity, and severity. , 1999, American journal of respiratory and critical care medicine.

[9]  A. Ruiz-González,et al.  Is Streptococcus pneumoniae the leading cause of pneumonia of unknown etiology? A microbiologic study of lung aspirates in consecutive patients with community-acquired pneumonia. , 1999, The American journal of medicine.

[10]  T. Ishida,et al.  Etiology of community-acquired pneumonia in hospitalized patients: a 3-year prospective study in Japan. , 1998, Chest.

[11]  J. Domínguez,et al.  Comparison of the Binax Legionella Urinary Antigen Enzyme Immunoassay (EIA) with the Biotest Legionella Urin Antigen EIA for Detection of Legionella Antigen in both Concentrated and Nonconcentrated Urine Samples , 1998, Journal of Clinical Microbiology.

[12]  Y. Ong,et al.  Aetiology and outcome of severe community-acquired pneumonia in Singapore. , 1998, The European respiratory journal.

[13]  M. Kolczak,et al.  Incidence of Community-Acquired Pneumonia Requiring Hospitalization Results of a Population-Based Active Surveillance Study in Ohio , 1997 .

[14]  S. Norrby Atypical pneumonia in the Nordic countries: aetiology and clinical results of a trial comparing fleroxacin and doxycycline. Nordic Atypical Pneumonia Study Group. , 1997 .

[15]  R. Peeling,et al.  Ambulatory patients with community-acquired pneumonia: the frequency of atypical agents and clinical course. , 1996, The American journal of medicine.

[16]  P. Saikku,et al.  Clinical picture of community-acquired Chlamydia pneumoniae pneumonia requiring hospital treatment: a comparison between chlamydial and pneumococcal pneumonia. , 1996, Thorax.

[17]  E. Manor,et al.  Multiple pathogens in adult patients admitted with community-acquired pneumonia: a one year prospective study of 346 consecutive patients. , 1996, Thorax.

[18]  M. Leinonen,et al.  The etiology of community-acquired pneumonia among hospitalized patients during a Chlamydia pneumoniae epidemic in Finland. , 1995, The Journal of infectious diseases.

[19]  Richard D Moore,et al.  Community-acquired pneumonia: impact of immune status. , 1995 .

[20]  C. Pugliese,et al.  Community-acquired pneumonia: is there difference in etiology between hospitalized and out-patients? , 1995, Minerva medica.

[21]  B. Afessa,et al.  Pneumococcal bacteremia in adults: a 14-year experience in an inner-city university hospital. , 1995, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[22]  Y. Shemer-Avni,et al.  Chlamydia pneumoniae-induced ciliostasis in ciliated bronchial epithelial cells. , 1995, The Journal of infectious diseases.

[23]  V L Yu,et al.  Guidelines for the initial management of adults with community-acquired pneumonia: diagnosis, assessment of severity, and initial antimicrobial therapy. American Thoracic Society. Medical Section of the American Lung Association. , 1993 .

[24]  C. Chan,et al.  Treatment of community-acquired pneumonia. A multicenter, double-blind, randomized study comparing clarithromycin with erythromycin. Canada-Sweden Clarithromycin-Pneumonia Study Group. , 1993, Chest.

[25]  J. Blanquer,et al.  Aetiology of community acquired pneumonia in Valencia, Spain: a multicentre prospective study. , 1991, Thorax.

[26]  Henry D. Isenberg,et al.  Manual of Clinical Microbiology , 1991 .

[27]  W. Kapoor,et al.  New and Emerging Etiologies for Community‐Acquired Pneumonia with Implications for Therapy: A Prospective Multicenter Study of 359 Cases , 1990, Medicine.

[28]  Watchara Boonsawat,et al.  Community-acquired pneumonia in adults at Srinagarind Hospital. , 1990, Journal of the Medical Association of Thailand = Chotmaihet thangphaet.

[29]  Ellen Jo Baron,et al.  Manual of clinical microbiology , 1975 .

[30]  A. M. Collier,et al.  Relationships Between Mycoplasma pneumoniae and Human Respiratory Epithelium , 1971, Infection and immunity.